Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
12-2015 | 11-2015 | 09-2015 | 08-2015 | 06-2015 | |
Sales | 4 | 4 | 6 | 6 | 4 |
Cost of Goods | 57 | 2 | 2 | 2 | 2 |
Gross Profit | 2 | 2 | 4 | 4 | 2 |
Operating Expenses | 38 | 1,980 | 1,672 | 1,670 | 2,102 |
Operating Income | -34 | -1,978 | -1,666 | -1,666 | -2,098 |
Interest Expense | -60 | 0 | 1 | 0 | 60 |
Other Income | -1,686 | 318 | 696 | 696 | 1,378 |
Pre-tax Income | -1,660 | -1,660 | -970 | -970 | -780 |
Net Income Continuous | -1,660 | -1,660 | -972 | -972 | -780 |
Net Income | $-1,660 | $-1,660 | $-972 | $-972 | $-780 |
EPS Basic Total Ops | -7.68 | -0.16 | -0.48 | -0.01 | -4.80 |
EPS Basic Continuous Ops | -7.47 | -0.16 | -0.44 | -0.01 | -3.52 |
EPS Diluted Total Ops | -7.68 | -0.16 | -0.48 | -0.01 | -4.80 |
EPS Diluted Continuous Ops | -7.47 | -0.16 | -0.44 | -0.01 | -3.52 |
EBITDA(a) | $1,308 | $-635 | $-2,128 | $-2,128 | $-1,628 |